Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
Authors
Keywords
-
Journal
Blood Advances
Volume 4, Issue 10, Pages 2143-2157
Publisher
American Society of Hematology
Online
2020-05-19
DOI
10.1182/bloodadvances.2019001091
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia
- (2019) Alak Manna et al. CLINICAL CANCER RESEARCH
- PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
- (2019) Vivek Verma et al. NATURE IMMUNOLOGY
- A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD + Decline
- (2018) Mariana G. Tarragó et al. Cell Metabolism
- CD38-NAD + Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response
- (2018) Shilpak Chatterjee et al. Cell Metabolism
- Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells
- (2018) Aneel Paulus et al. BRITISH JOURNAL OF HAEMATOLOGY
- Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects
- (2017) Gayane Manukyan et al. Oncotarget
- Circulating Regulatory T Cells in “Clinical” Monoclonal B-Cell Lymphocytosis
- (2017) G. D'Arena et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment
- (2016) Elisa ten Hacken et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
- (2016) J. Krejcik et al. BLOOD
- The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia
- (2016) Alba Matas-Céspedes et al. CLINICAL CANCER RESEARCH
- T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
- (2016) Marzia Palma et al. HAEMATOLOGICA
- Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice
- (2016) Rituparna Das et al. NATURE MEDICINE
- Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade
- (2016) Sarah E.M. Herman et al. SEMINARS IN ONCOLOGY
- Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia
- (2016) Patricia A. Toniolo et al. Oncotarget
- T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
- (2016) Marzia Palma et al. HAEMATOLOGICA
- Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia
- (2016) Audrey Mohr et al. OncoImmunology
- Perturbation of the normal immune system in patients with CLL
- (2015) F. Forconi et al. BLOOD
- The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia
- (2015) Mehdi Yousefi et al. Future Oncology
- Regulatory B Cells: Origin, Phenotype, and Function
- (2015) Elizabeth C. Rosser et al. IMMUNITY
- Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors
- (2015) Curt D. Haffner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia
- (2014) Anne Rissiek et al. INTERNATIONAL JOURNAL OF CANCER
- A study for proposal of use of regulatory T cells as a prognostic marker and establishing an optimal threshold level for their expression in chronic lymphocytic leukemia
- (2014) Alakananda Dasgupta et al. LEUKEMIA & LYMPHOMA
- The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
- (2013) Gabriele Brachtl et al. ANNALS OF HEMATOLOGY
- Identification of IFN-γ-producing innate B cells
- (2013) Yan Bao et al. CELL RESEARCH
- Th17/IL-17A Might Play a Protective Role in Chronic Lymphocytic Leukemia Immunity
- (2013) Iwona Hus et al. PLoS One
- CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation
- (2013) F. Flores-Borja et al. Science Translational Medicine
- How the microenvironment wires the natural history of chronic lymphocytic leukemia
- (2013) Federico Caligaris-Cappio et al. SEMINARS IN CANCER BIOLOGY
- T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
- (2012) A. Facciabene et al. CANCER RESEARCH
- Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
- (2012) D J DiLillo et al. LEUKEMIA
- Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia
- (2012) Farhad Jadidi-Niaragh et al. TUMOR BIOLOGY
- REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
- (2012) Giovanni D'arena et al. Mediterranean Journal of Hematology and Infectious Diseases
- Flavonoids as inhibitors of human CD38
- (2011) Esther Kellenberger et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- CD38 and chronic lymphocytic leukemia: a decade later
- (2011) F. Malavasi et al. BLOOD
- Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
- (2011) X.-J. Yan et al. BLOOD
- Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response
- (2011) Asher A. Chanan-Khan et al. BRITISH JOURNAL OF HAEMATOLOGY
- The PI3K p110δ Regulates Expression of CD38 on Regulatory T Cells
- (2011) Daniel T. Patton et al. PLoS One
- Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia
- (2010) Lukas Weiss et al. CANCER
- Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response
- (2010) Asher Chanan-Khan et al. CANCER
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells
- (2009) Irina Idler et al. BRITISH JOURNAL OF HAEMATOLOGY
- CD38-mediated Ca2+Signaling Contributes to Angiotensin II-induced Activation of Hepatic Stellate Cells
- (2009) Seon-Young Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhanced formation and survival of CD4+CD25hiFoxp3+T-cells in chronic lymphocytic leukemia
- (2009) Margot Jak et al. LEUKEMIA & LYMPHOMA
- How Diverse--CD4 Effector T Cells and their Functions
- (2009) Y. Y. Wan et al. Journal of Molecular Cell Biology
- Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology
- (2008) Fabio Malavasi et al. PHYSIOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search